Quality Improvement for Institutions
www.cvquality.acc.org
  1. Home
  2. News

What's New at NCDR and ACC Accreditation Services

Stay up to date with the latest news from ACC NCDR and Accreditation Services, where data, accreditation and collaboration come together to drive meaningful improvements in cardiovascular care.

Celebrating Ten Years of Excellence

As ACC NCDR and Accreditation Services celebrates 10 years together, we reflect on a decade of progress, collaboration, and measurable improvement in cardiovascular care. Together with our partners, we remain focused on driving innovation, quality, and better outcomes for patients nationwide.

New Accreditation Designation

10 Years Together

NEW Chest Pain Center Accreditation Cardiogenic Shock Designations!

New standards focused on early recognition and escalation of cardiogenic shock. Presales will be available in late spring 2026. Stay tuned for tools and resources to support your planning.

News Stories and Journal Scans

Explore the latest ACC NCDR and Accreditation articles and stay informed about updates, insights and key developments.

CMS Proposes Updates to TAVR National Coverage Determination

View Article

ACC Streamlines Cardiac Accreditation for Hospital Systems

View Article

ACC HeartCARE Center Designation Hits 100 Hospital Milestone

View Article

NCDR Study: Prevalence and Outcomes of PCI Performed at Facilities Without On-Site Cardiac Surgery

View Article

NCDR Study: Off-Label Transcatheter Tricuspid Valve Interventions Demonstrate Reduced Residual TR, Improved QOL

View Article

QI.PI Project Grant Recipient Develops Digital Biomarker for PAD Screening


View Article

Stay Connected to Quality and Practice Excellence

U.S. News and World Report

In the 2026 U.S. News and World Report "Best Hospitals" issues annual ad insert, the ACC recognizes the more than 2,000 hospitals, health systems and centers participating in NCDR and/or Accreditation Services.

 

ACC CV Quality SmartBrief

The ACC CV Quality SmartBrief eNewsletter is a free, twice-weekly briefing for health care stakeholders interested in quality care.

Learn more about the ACC CV Quality SmartBrief and subscribe.

Connect Through DocMatter

ACC members can deepen their engagement through DocMatter, the College's exclusive, secure online community. DocMatter connects over 65,000 cardiovascular professionals to provide a trusted space to exchange insights, discuss clinical and operational challenges, and stay informed about ACC NCDR and Accreditation programs and initiatives.

ACC members can access DocMatter as part of their membership.

From The ACC

Explore the latest news and insights from the American College of Cardiology shaping cardiovascular quality, care delivery, and accreditation.

  • ED readiness for pediatric care can affect mortality

    A study in JAMA Pediatrics found that a loss or persistent lack of emergency department pediatric readiness and inpatient services was associated with higher in-hospital mortality for pediatric patients. The study analyzed data from 759 hospitals across 11 states, involving more than 2.4 million children receiving emergency care between 2012 and 2021. Medscape (9/8) Learn More

  • AI supports adult, pediatric care via federal agencies

    Federal health agencies are using artificial intelligence to enhance care for children and adults. The Advanced Research Projects Agency for Health's Pediatric Care eXpansion program aims to connect more than 200 children's hospitals to improve data interoperability and patient outcomes. HRSA is using AI to prevent nursing home injuries by monitoring patient movements, and the Department of Veterans Affairs developed a virtual training system for clinicians that uses AI-generated virtual patients and immersive environments. GovCIO Media & Research (9/4) Learn More

  • Long COVID research points to new treatment strategies

    Researchers are increasingly linking long COVID and other post-infection illnesses to overlapping mechanisms including immune dysfunction, autoantibodies and persistent viral material, raising the possibility that patients may eventually be divided into biological subgroups for targeted treatment. Early studies of approaches including antibody removal, B-cell-targeting drugs and antiviral combinations have shown promising signals, but validated biomarkers and larger controlled trials are still needed. Nature (9/2) Learn More

  • System uses temporary leadership to engage more physicians

    Providence has implemented temporary physician leadership positions to allow them to engage in activities without requiring a long-term commitment. This approach allows physicians to take on leader roles that fit their schedules and interests, says Dr. Brendan Lloyd, chief medical officer for care delivery. Temporary roles also enable physicians with demanding clinical responsibilities, such as busy hospitalists, to contribute their expertise in targeted, short-term projects. Becker's Clinical Leadership & Infection Control (9/3) Learn More

  • Software helps to reduce unnecessary catheterizations

    Heartflow's FFRCT Analysis software, which uses artificial intelligence to evaluate coronary CT angiography scans, has been linked to a significant decrease in unnecessary catheterizations, according to data from the FUSION trial presented at the European Society of Cardiology Congress and published in JACC. The study found that FFRCT-guided care led to a 44% relative reduction in patients undergoing invasive coronary angiography without signs of coronary artery disease, without compromising patient safety or quality of care. Cardiovascular Business (8/28) Learn More

  • AI scribes may overlook patient experience, pose risks

    A review by researchers in Scotland found that AI scribes often overlook patient experiences, potentially affecting marginalized groups. The review, published in BMJ Digital Health & AI, highlights that while the scribes are praised for reducing paperwork, they may miss nonverbal cues and patient narratives, which can affect quality of care. Medical Economics (9/4) Learn More

  • New artificial heart shows promise

    Carmat's Aeson total artificial heart has shown promising results in the EFICAS study, with 72.7% of patients meeting the primary endpoint of 180-day survival without disabling stroke or device malfunction. The study, presented at the European Society of Cardiology Congress, included 55 patients with advanced heart failure. The device also improved patients' functional status and quality of life. Medscape (9/4) Learn More

Temp Styles

American College of Cardiology: 2400 N St. NW, Washington DC 20006